第二轮通知日程.doc

Cancer Prevention, Biomarkers and Screening Research in China and the United States: Opportunities for Collaboration A Workshop Organized by: Cancer Institute & Hospital, Chinese Academy of Medical Sciences & U.S. National Cancer Institute ~~~~~~~~~~~~~~ CICAMS, Beijing, China May 9 – 11, 2012 This workshop will convene scientists, clinicians, and government officials to discuss cancer prevention and screening research, including clinical trials of cancer screening, community based cancer screening programs, and biomarker studies. The workshop will review the status of research in these areas in the U.S. and China, and explore possible opportunities for future collaboration. The first day of the workshop will focus on cancer screening and early detection. The second day of the workshop will focus on biomarker studies, which provide important tools for screening, early detection, and cancer prevention in clinical trials and community based screening programs. The third day of the workshop will focus on funding opportunities and roundtable discussions of China-U.S. collaborations by tumor site. ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ Version 2/1/2025 1 May 9 (Day 1) – Radegast Lake View Hotel, Lecture Hall, 5th Floor 8:00 a.m. – 8:30 a.m. Registration and Coffee Opening Session Co-Chairs: Dr. Yixin Zeng, CICAMS and Dr. Julie Schneider, NCI 8:30 a.m. – 9:00 a.m. Welcome Remarks TBD, Ministry of Health, P.R. China U.S. Embassy Deputy Chief of Mission Robert Wong Dr. Barry Kramer, NCI 9:00 a.m. – 9:45 a.m. Keynote Address Cancer Prevention and Control in China Dr. Lingzhi Kong, Ministry of Health, P.R. China 9:45 a.m. – 10:30 a.m. Perspectives on Screening Research and Implementation in the United States Over the Last 50 Years Dr. Barry Kramer, NCI 10:30 a.m. – 11:00 a.m. GROUP PHOTO AND BREAK Cancer Screening Research Session 1: Clinical Trials of Cancer Screening Co-Chairs: Dr. Mingrong Wang, CICAMS and Dr. Ping Hu, NCI 11:00 a.m. – 11:30 a.m. Screening and Prevention Trials of Nasopharyngeal Cancer in China Dr. Yixin Zeng, Peking Union Medical College 11:30 a.m. – 12:00 p.m. Recently Concluded U.S. Lung Cancer Randomized Controlled Trials: The National Lung Screening Trial and the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Dr. Philip Prorok, NCI 12:00 p.m. – 12:15 p.m. Q & A and panel discussion 12:15 p.m. – 1:30 p.m. LUNCH Session 2: Community-Based Cancer Screening Programs – Esophageal and Lung Cancer Co-Chairs: Dr. Xiuyi Zhi, Beijing Xuan-Wu Hospital and LCDR Alden Chiu MD, Uniformed Services University of the Health Sciences and NCI 1:30 p.m. – 1:50 p.m. Version 2/1/2025 Population-based Esophageal Cancer Screening and Early Treatment in China Dr. Jie He, CICAMS 2 1:50 p.m. – 2:10 p.m. Esophageal Cancer Screening in the U.S. Dr. Philip Taylor, NCI 2:10 p.m. – 2:30 p.m. Lung Cancer Screening in the U.S. Dr. Pam Marcus, NCI 2:30 p.m. – 2:50 p.m. Lung Cancer Screening in China Dr. Qinghua Zhou, Tianjin Medical University General Hospital 2:50 p.m. – 3:05 p.m. BREAK Session 3: Community-Based Cancer Screening Programs – Breast and Cervical Cancer Co-Chairs: Dr. Xiang Wang, CICAMS and Dr. Philip Castle, ASCP 3:05 p.m. – 3:25 p.m. Initiatives to Evaluate Community-based Breast and Cervical Cancer in the U.S.: The Breast Cancer Surveillance Consortium and PROSPR initiative Dr. Paul Doria-Rose, NCI 3:25 p.m. – 3:45 p.m. Breast Cancer Screening Program in China Dr. Kexin Chen, Tianjin Cancer Center and China Anticancer Association 3:45 p.m. – 4:05 p.m. Cervical Cancer Screening Program in China Dr. Youlin Qiao, CICAMS 4:05 p.m. – 4:20 p.m. Q & A and panel discussion 4:20 p.m. – 4:35 p.m. BREAK Session 4: The Role of Cancer Surveillance and Registration in Cancer Screening Research Co-Chairs: Dr. Yu Wang, China CDC and Dr. Mike Engelgau, U.S. CDC 4:35 p.m. – 4:55 p.m. National Cancer Registration & Surveillance in China Dr. Wanqing Chen, CICAMS 4:55 p.m. – 5:15 p.m. Developing Cancer Registries to Support Cancer Screening research Dr. Brenda Edwards, NCI 5:15 p.m. – 5:30 p.m. Q & A and panel discussion 5:30 p.m. – 5:45 p.m. Closing Remarks Dr. Barry Kramer, NCI Version 2/1/2025 3 May 10 (Day 2) – Cancer Biomarkers: Advancing Biomarkers Research for Cancer Early Detection, Diagnosis, Prediction, and Prevention, Radegast Lake View Hotel, Lecture Hall, 5th Floor 7:30 a.m. – 8:00 a.m. Registration and Coffee Session 5: Overview of Cancer Prevention and Biomarkers Research Co-Chairs: Dr. Qimin Zhan, CICAMS and Dr. Leslie Ford, NCI 8:00 a.m. – 8:30 a.m. Keynote Address Early Detection Research Network (EDRN) Dr. Sudhir Srivastava, NCI 8:30 a.m. – 9:00 a.m. Biomarker Discovery for Cancers Dr. Jing Cheng, Tsinghua University 9:00 a.m. – 9:30 a.m. Biomarker Research on Breast Cancer: New Technology Dr. Joshua Labaer, Arizona State University 9:30 a.m. – 10:00 a.m. Q & A and panel discussion 10:00 a.m. – 10:15 a.m. BREAK Session 6: Discovery and Development of Cancer Biomarkers Co-Chairs: Dr. Zhihua Liu, CICAMS and Dr. Julie Schneider, NCI 10:15 a.m. – 10:45 a.m. Opportunities for Collaborative Integrative Approaches to Lung Cancer Research Dr. Samir Hanash, Fred Hutchinson Cancer Research Center 10:45 a.m. – 11:15 a.m. Lung Cancer Biomarker Studies in China Dr. Yanning Gao, CICAMS 11:15 a.m. – 11:45 a.m. Biomarker Studies of Esophageal Cancer in China Dr. Christine Abnet, NCI 11:45 a.m. – 12:15 p.m. Evolution of Biomarkers of Cervical Cancer Dr. Philip Castle, American Society for Clinical Pathology 12:15 a.m. – 12:30 p.m. Q & A and panel discussion 12:30 p.m. - 1:30 p.m. LUNCH Session 7: Cancer Genomics, Prevention, and Applications Co-Chairs: Dr. Dongxin Lin, CICAMS and Dr. Wendy Wang, NCI 1:30 p.m. – 2:00 p.m. HapMap and Cancer Genomics in China Dr. Guoping Zhao, Fudan University 2:00 p.m. – 2:30 p.m. Cancer Genomics and Biomarkers Version 2/1/2025 4 Dr. Avrum Spira, Boston University School of Medicine 2:30 p.m. – 3:00 p.m. Human Lung Developmental Gene Signature Predicts Prognosis in Lung Adenocarcinoma Dr. Shujun Cheng, CICAMS 3:00 p.m. – 3:15 p.m. Q & A and panel discussion 3:15 p.m. – 3:30 p.m. BREAK Session 8: Cancer Biomarker Research for Early Diagnosis and Prevention Co-Chairs: Dr. Ningzhi Xu, CICAMS and Dr. Joshua Labaer, ASU 3:30 p.m. – 4:00 p.m. Molecular Biomarkers Research for Individualized Medicine Dr. Qimin Zhan, Chinese Academy of Medical Science 4:00 p.m. – 4:30 p.m. Molecular Cancer Biomarkers for Diagnosis Dr. Mao Li, University of Maryland School of Dentistry, Baltimore 4:30 p.m. – 5:00 p.m. Cancer Biomarker Validation Design: Liver Cancer Dr. Ziding Feng, Fred Hutchinson Cancer Research Center 5:00 p.m. – 5:20 p.m. Protein Kinases as Biomarkers and Targets for Prevention of Cancer Dr. Zigang Dong, University of Minnesota Cancer Center 5:20 p.m. – 5:35 p.m. Q & A and panel discussion May 11 (Day 3) – Introduction to Funding Opportunities and Roundtable Discussions (by invitation only), Radegast Lake View Hotel, Room C801 8th Floor Session 9: Special Invited Lectures – Funding Opportunities to Support U.S.-China Research Cooperation Moderators: Dr. Mingrong Wang, CICAMS and Dr. Heng Xie, NIH 8:30 a.m. – 9:30 a.m. NIH Funding Mechanisms to Support Translational Sciences and International Collaboration Dr. Heng Xie, NIH Funding Mechanisms to Support International Collaboration Ruiguo Li, Ministry of Science and Technology NSFC's Funding Mechanisms to Support International Collaboration Dr. Xiuping Liu, National Natural Science Foundation of China Version 2/1/2025 5 NIH – National Natural Science Foundation of China Program for Biomedical Research Cooperation Dr. Julie Schneider, NCI Funding Mechanisms to Support International Collaboration Fengyun Lei, Bureau of Foreign Experts, Ministry of Human Resources Roundtable Discussion - Cancer Clinical Trials and Biomarker Research Moderators: Dr. Ningzhi Xu, CICAMS and Dr. Barry Kramer, NCI 9:30 a.m. – 10:45 a.m. Esophageal Cancer Topic: Potential collaboration possibilities for new cancer screening and biomarker initiatives 10:45 a.m. – 11:00 a.m. BREAK 11:00 a.m. – 12:15 p.m. Lung Cancer Topic: Potential collaboration possibilities for new cancer screening and biomarker initiatives 12:15 p.m. – 1:30 p.m. LUNCH Roundtable Discussion – Cancer Clinical Trials and Biomarker Research Moderators: Dr. Youlin Qiao, CICAMS and Dr. Sudhir Srivastava, NCI 1:30 p.m. – 2:45 p.m. Breast Cancer Topic: Potential collaboration on program management, biomarker research, and evaluation of existing screening initiatives 2:45 p.m. – 4:00 p.m. Cervical Cancer Topic: Potential collaboration on program management, biomarker research, and evaluation of existing screening initiatives 4:00 p.m. - 4:15 p.m. BREAK Roundtable Discussion – Cancer Surveillance Moderators: Dr. Wanqing Chen, CICAMS and Dr. Brenda Edwards, NCI 4:15 p.m. – 5:30 p.m. Cancer Surveillance Topic: The quality of cancer registration and use for cancer prevention and control Closing Session 5:30 p.m. – 6:00 p.m. Summary, Next Steps, and Closing Remarks Dr. Jie He, CICAMS and Dr. Ted Trimble, NCI ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ Version 2/1/2025 6 Radegast Lake View Hotel 北京康源瑞廷酒店 No 19, Pan Jia Yuan South Road, Chaoyang District, Beijing 北京市朝阳区潘家园南里19号 Tel: (86 10) 5909 7777 Fax: (86 10) 5909 7788 http://www.radegasthotel.com/ Version 2/1/2025 7